AAM Applauds FTC-HHS Probe Into Generic Drug Shortages
The Inquiry Will Focus On GPOs and Drug Wholesalers
As two US governmental agencies launch an investigation into the potential causes of drug shortages, AAM says the generics industry faces “unprecedented threats.”